论文部分内容阅读
Objectives:The AS04-adjuvanted HPV-16 and 18 vaccine (AS04-adjuvanted vaccine) has recently been approved as a 2-dose schedule in girls from 9 to 14 years of age in different countries including Nigeria.This analysis aims to evaluate the cost-consequence of switching from an AS04-adjuvanted vaccine 3-dose to a 2-dose vaccination schedule.